Open an account

Adapthealth

AHCO · NASDAQ

$6.10+$0.22 (+3.74%)TodayMarket closed ·
Prev close $5.88

About AHCO

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Conshohocken, Pennsylvania and currently employs 10,900 full-time employees. The company went IPO on 2018-02-21. The firm provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home. Its product and service offerings include sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea; medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors and insulin pumps; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The company operates in 50 states through its network of over 670 locations in 47 states.

Employees
10,900
Headquarters
Conshohocken, Pennsylvania
Listed
Feb 21, 2018
Sector
Health Care
Industry
Health Care Providers & Services
Website
adapthealth.com

AHCO key statistics

Market cap
801.70M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
2.26M
Volume
2.24M
Open price
$5.94
High today
$6.12
Low today
$5.88
52 Week high
$13.43
52 Week low
$5.21

Adapthealth (AHCO) at a glance

Adapthealth (AHCO) last traded at $6.10, with a market cap of 801.70M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $5.88 and $6.12. The current price is 3.7% above the day's low and 0.2% below its high.

Volume so far is 2.24M shares, in line with the average of 2.26M shares a day.

Over the past year Adapthealth has ranged from $5.21 to $13.43, and now sits 11% of the way up that range.

Adapthealth met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY26 it reported $0.09 per share against an estimate of $0.1734.

The average analyst price target is $9.18, 50.5% above the current price, from 7 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 7 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 9 analystsAvg $9.18
Low
$7.07
Now
$6.10
High
$10.50

AHCO earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 35.5% on average.

  1. Q3 FY24: reported $0.15 per share against an estimate of $0.1693
  2. Q4 FY24: reported $0.34 per share against an estimate of $0.2509
  3. Q1 FY25: reported -$0.05 per share against an estimate of $0.0041
  4. Q2 FY25: reported -$0.13 per share against an estimate of $0.1173
  5. Q3 FY25: reported $0.16 per share against an estimate of $0.2474
  6. Q4 FY25: reported -$0.76 per share against an estimate of $0.357
  7. Q1 FY26: reported -$0.12 per share against an estimate of $0.0175
  8. Q2 FY26: reported $0.09 per share against an estimate of $0.1734

AHCO news

  • Press releaseBusiness Wire

    AdaptHealth To Participate in Upcoming Investor Conferences

  • Press releaseBusiness Wire

    AdaptHealth Appoints Harriss Currie as Chief Financial Officer

  • Press releasePRNewswire

    ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health

  • Press releaseGlobe Newswire

    AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information

  • Press releasePRNewswire

    AdaptHealth Corp. (AHCO) Securities Investigation Notice - Levi & Korsinsky

  • Press releaseBusiness Wire

    AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law

  • Press releaseBusiness Wire

    AdaptHealth Corp. to Participate in Upcoming Investor Conferences

  • Press releaseBusiness Wire

    AHCO Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AdaptHealth Corp. (AHCO)

Similar companies

Companies in the same industry as Adapthealth

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.